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Lipid Coated Microbubbles and 
Low Intensity Pulsed Ultrasound 
Enhance Chondrogenesis of Human 
Mesenchymal Stem Cells in 3D 
Printed Scaffolds
Mitra Aliabouzar1, Lijie Grace Zhang1,2,3 & Kausik Sarkar1
Lipid-coated microbubbles are used to enhance ultrasound imaging and drug delivery. Here we apply 
these microbubbles along with low intensity pulsed ultrasound (LIPUS) for the first time to enhance 
proliferation and chondrogenic differentiation of human mesenchymal stem cells (hMSCs) in a 3D 
printed poly-(ethylene glycol)-diacrylate (PEG-DA) hydrogel scaffold. The hMSC proliferation increased 
up to 40% after 5 days of culture in the presence of 0.5% (v/v) microbubbles and LIPUS in contrast 
to 18% with LIPUS alone. We systematically varied the acoustic excitation parameters—excitation 
intensity, frequency and duty cycle—to find 30 mW/cm2, 1.5 MHz and 20% duty cycle to be optimal 
for hMSC proliferation. A 3-week chondrogenic differentiation results demonstrated that combining 
LIPUS with microbubbles enhanced glycosaminoglycan (GAG) production by 17% (5% with LIPUS 
alone), and type II collagen production by 78% (44% by LIPUS alone). Therefore, integrating LIPUS 
and microbubbles appears to be a promising strategy for enhanced hMSC growth and chondrogenic 
differentiation, which are critical components for cartilage regeneration. The results offer possibilities 
of novel applications of microbubbles, already clinically approved for contrast enhanced ultrasound 
imaging, in tissue engineering.
Cartilage regeneration remains one of the prized goals of tissue engineering because of the notorious difficulties 
of the cartilage repair process1. In recent years, tissue engineering approaches have focused on human mesen-
chymal stem cells (hMSCs) as an important cell source2–5 for their ability to differentiate into many cell types6. 
The underlying guiding principle is that the hMSCs would differentiate into a particular cell type and grow the 
corresponding tissue when directed by the appropriate chemical (e.g. appropriate growth factors) and mechani-
cal cues supplied in the environment7–9. Cartilage and bone cells are known to respond favorably to mechanical 
stresses due to ultrasound10–13. Here we have investigated for the first time the effects of lipid-coated microbubbles 
(MBs) in presence of low intensity pulsed ultrasound (LIPUS) on chondrogenic differentiation of hMSCs in a 
three-dimensional (3D) printed scaffold.
Over the past few decades, the medical use of ultrasound has been extended beyond imaging and diagnosis 
towards therapeutic applications. Therapeutic effects of LIPUS, with frequency ranging from 0.75 to 1.5 MHz 
and intensity lower than 100 mW/cm2, have been investigated in a number of applications including fracture 
healing10,14–16, wound healing17 and treatment of glaucoma18. Although LIPUS has been approved for treatment 
of fresh as well as non-union fractures by the US Food and Drug Administration, its practical use for cartilage 
repair in a clinical setting has so far been limited19. To shed light on this matter, several studies have investigated 
the effects of LIPUS on chondrocyte viability and proliferation13,20,21, gene expression22, type II collagen23,24, type 
X collagen20 and glycosaminoglycan (GAG) syntheses25,26. Parvizi et al. reported that LIPUS stimulation on rat 
chondrocytes improved aggrecan mRNA expression and proteoglycan synthesis27. Hasanova et al. demonstrated 
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that LIPUS treated chondrocytes seeded in three-dimensional (3D) chitosan-based matrices had higher levels of 
type II collagen, aggrecan, L-Sox5 and Sox9 mRNA expression when compared to controls28. Increased expres-
sion of type II collagen, aggrecan mRNA, and proteoglycan synthesis, which are all crucial in regulation of chon-
drocytes, have been reported in past studies23–25,29,30.
Here, we have used lipid-coated MBs in order to better harness the beneficial effects of LIPUS stimulation on 
proliferation and chondrogenic differentiation of hMSCs. These gas-filled MBs are highly responsive to ultra-
sound, which has led to their application as ultrasound contrast agents (UCA)31–33. Currently, their use in facili-
tating delivery of therapeutics to tissues and organs through sonoporation is being actively investigated34–39. They 
are also being applied for embolotherapy40, accelerated thrombolysis41,42 and hyperthermia-induced apoptosis43. 
However, the combination of LIPUS and MBs has not been previously studied for cartilage tissue regeneration.
Most of the in vitro experiments investigating effects of LIPUS on cells were conducted in two-dimensional 
(2D) cell cultures or hydrogel thin films12,44, an environment very different from the one cells find inside the 
body. Recently, 3D printing has emerged as a leading technique to create tissue scaffolds incorporating intricate 
hierarchical structures of the native tissue as well as the patient specific geometry of target injury sites obtained 
by CT images45. Three dimensional tissue scaffolds can provide physiological environment for cells within the 
body unavailable in a traditional 2D setting. Here we have used a 3D tissue scaffold made of Poly-(ethylene 
glycol)-diacrylate (PEGDA) printed by a novel tabletop stereolithography-based technique developed in our 
lab46,47. PEGDA, as a UV photocurable bioink, is chosen for its high water content, biocompatibility and easy 
printability48.
The objective of the present work is to investigate the effects of LIPUS on growth and chondrogenic differen-
tiation of hMSCs within a 3D printed matrix, in the presence of MBs. We have thoroughly evaluated the 1, 3 and 
5-day proliferation as well as three-week chondrogenic differentiation of hMSCs in 3D printed scaffolds under 
LIPUS and MB treatment.
Results and Discussion
Characterization of 3D-printed scaffolds. In our previous studies without MBs, scaffolds with square 
channels presented highest hMSC growth and differentiation compared to other pore geometries47. Therefore, we 
chose this pore geometry for our current studies as well.
Figure 1(a) shows a schematic representation of the 3D printer described in section 4.1. A scanning electron 
microscope (SEM, Zeiss NVision 40FIB) was employed to assess the matrix morphology and pore size. Typical 
SEM images of 3D-printed scaffolds with square pore shapes are presented in Fig. 1(b,c). Using Image J software 
(imagej.nih.gov), the pore dimension was found to be 700 × 690 μ m2. The porosity of the scaffold was 49%. We 
calculated the porosity by measuring its solid phase density as well as apparent mass density according to49. All 
the measurements were repeated 6 times from different positions of the printed scaffolds.
Figure 1. (a) A schematic of stereolithagraphy based 3D printer, (b,c) SEM micrographs of 3D printed cartilage 
scaffolds with square channels. The scale bar represents 200 μ m.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:37728 | DOI: 10.1038/srep37728
Lipid-coated microbubbles. We have used lipid-coated MBs made in-house with a perfluorobutane 
gas core for this study. The MB preparation method is detailed in section 4.2. Bubble production was verified 
by measuring acoustic scattering as described in our previous publications33,50,51. MBs created by the standard 
mechanical agitation technique have a broad size distribution as can be seen in Fig. 2(a). To make the size distri-
bution narrower (more monodisperse), we followed a simple and rapid technique of differential centrifugation 
according to refs 52 and 53. Figure 2 (a,b) show that a 2-minute centrifugation at 40 relative centrifugal force 
(RCF) reduced the average size of MBs from 1.3 μ m to 800 nm.
Cytotoxicity of lipid-coated microbubbles. The cytotoxicity of the lipid-coated MBs synthesized in 
house was investigated by incubating cells with varying concentrations (0.5, 1, 2, 4, 5 and 10% v/v) of MB sus-
pension for over 72 hours. The viability of the cells incubated with the MB suspension compared to those without 
MB (0% MB) was determined using the MTS assay and presented in Fig. 3. The results show an increased cell 
proliferation both after 24 and 72 hour time periods. Due to gas diffusion from the surrounding non-degassed 
PBS (phosphate buffer saline) during centrifugation, MBs were partially filled with air54–56. Observed increased 
cell proliferation in the presence of MBs might be ascribed to increased oxygen available to the cells. Overall, the 
Figure 2. Size distribution and concentration determined using qNano system for lipid-coated microbubbles 
produced by mechanical agitation (a) before and (b) after centrifugation. Optical microscopy images (c) before 
and (d) after differential centrifugation. The scale bar is 100 μm.
Figure 3. Short (1 day)- and long (3 day)-term cell viability assay results of hMSCs incubated with lipid-coated 
microbubbles (Data are mean ± StdEM, n = 9).
www.nature.com/scientificreports/
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results indicated that lipid-coated microbubbles do not cause short-term or long-term cytotoxicity to the cells at 
the concentrations studied here.
Effect of LIPUS on hMSC proliferation in the presence of microbubbles. In order to determine the 
optimal concentration of MBs for ultrasound excitation studies, varying concentrations of MB suspension was 
added to the cell media. Following the addition of MBs, LIPUS (30 mW/cm2; 1.5 MHz; 200 μ s pulse length; duty 
cycle 20% i.e. PRF 1 kHz) was applied for three minutes. hMSC proliferation, 24 h after LIPUS stimulation, was 
examined and the results are presented in Fig. 4. It shows that LIPUS alone increased cell proliferation but not 
significantly. However, LIPUS-treated cells in the presence of 0.5% (v/v) MB suspension resulted in the highest 
proliferation rate. Ultrasound in the presence of higher concentrations of MBs decreased hMSC proliferation.
Consequently, we conducted 1, 3 and 5-day hMSC proliferation with LIPUS excitation in the presence of 0.5% 
(v/v) MB. We divided the samples into three groups: control (no LIPUS, no MB), LIPUS only, and LIPUS and 
MB. At predetermined time points, the cell viability was measured by an MTS assay with the results shown in 
Fig. 5(a). A significant increase in cell proliferation (p < 0.01) was observed with LIPUS treatment in the presence 
of optimal MB suspension after 1, 3 and 5 days of culture. hMSC proliferation enhanced up to 40% compared to 
the control (without MB and LIPUS) after 5 days of culture in the presence of MB and LIPUS while this value was 
only 18% when excited with LIPUS alone.
Figure 5(b),(c) and (d) show comparative microscopic images of hMSC cells—control, LIPUS without MB, 
and LIPUS with MB groups—demonstrating the beneficial effects of LIPUS, strongest in presence of MB.
Determination of optimum LIPUS parameters for hMSC proliferation in the presence of micro-
bubbles. Excitation intensity. The optimal LIPUS excitation was determined by evaluating hMSC prolifera-
tion under various intensities (10, 30, 70, 100, 150 and 300 mW/cm2). Other acoustic parameters (1.5 MHz, 20% 
duty cycle and 200 μ s pulse length) were kept the same. After 24-hour culture, hMSC proliferation was evaluated 
in response to 3 minutes of exposure to LIPUS in the presence of 0.5% MB suspension. As demonstrated in 
Fig. 6 (a), cell proliferation increased approximately by 20% at 30 mW/cm2 on day 1. At higher intensities, the 
proliferation diminished. The intensity was kept constant at 30 mW/cm2 for the rest of the studies. It is note-
worthy to mention that our previous study showed that 100 mW/cm2 intensity resulted in the maximum hMSC 
proliferation rate without the presence of MBs (data not shown here). As expected, addition of MBs has lowered 
the energy threshold required for enhancing cell growth.
Excitation duty cycle. We investigated the effects of duty cycle over the range of 0.02–80% (i.e., pulse repetition 
period (PRP) over 250 μ s to 1 s). The intensity, frequency and excitation duration were kept fixed at 30 mW/cm2, 
1.5 MHz and 3 min. Duty cycle is an important, yet the least studied, acoustic parameter in the literature. It is the 
fraction of the time within a pulse period the transducer is transmitting (pulse length/PRP). Figure 6(b) demon-
strates that at this intensity, LIPUS in the presence of MB tends to enhance hMSC proliferation when the PRP is 
between 1 to 100 ms, (i.e. duty cycle 20% to 0.2%). Shorter PRPs (corresponding to higher duty cycles) decreased 
cell proliferation. Consequently, PRP of 1 ms (duty cycle of 20%) was used for subsequent experiments.
Excitation frequency. To obtain the optimum excitation frequency, we varied it keeping pulse duration (200 μ 
s) and PRP (1 ms) constant. The intensity, duty cycle and excitation period were kept fixed at 30 mW/cm2, 20% 
and 3 min. Figure 6(c) shows that all three frequencies promoted hMSC proliferation with the increase being 
Figure 4. Effects of 3-min LIPUS (30 mW/cm2; 1.5 MHz; 20% duty cycle; 200 μs pulse length) at different 
concentrations of MB suspension on hMSC proliferation after 24 hrs (Data are mean ± StdEM, n = 9). Values 
significantly different from the control group are indicated by *for p < 0.05.
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statistically significant at 1.5 and 2.25 MHz. We chose frequency of 1.5 MHz, which has shown high promise for 
bone fracture healing, and kept it constant for subsequent studies.
Excitation duration. We also investigated the dependence of hMSC proliferation on the ultrasound excitation 
duration, we varied it to 1, 3 and 5 minutes following addition of 0.5% MB, keeping the intensity, duty cycle and 
frequency fixed at 30 mW/cm2, 20% and 1.5 MHz. As can be seen in Fig. 6(d) ultrasound stimulation in the 
presence of MB has significantly increased hMSC proliferation for all the time periods studied here compared to 
the control. Note that the variation in the control data across Fig. 6(a–d) are due to different donors and environ-
mental factors.
Effect of LIPUS treatments on hMSC chondrogenic differentiation in 3D-printed scaffolds in 
the presence of MB. In our previous investigation of hMSC growth and chondrogenic differentiation with-
out MBs, scaffolds with square pore geometry performed better than those with hexagonal pore geometry47. 
Therefore, scaffolds with square pore geometry were chosen here for hMSC chondrogenic differentiation evalua-
tions. We divided the samples into three groups: control group (no LIPUS, no MB), LIPUS only and LIPUS + MB 
group. Seeded 3D-printed PEGDA scaffolds were evaluated for GAG and type II collagen after three weeks of 
culture. Glycosaminoglycan (GAG) and collagen type II, which are two key components of a cartilage matrix, 
were measured using standard assay kits following manufacturer’s instructions. Figure 7(a) shows that all LIPUS 
treated samples exhibited an increase in GAG production; however, the increase is significantly higher upon 
incorporation of MBs when compared to the controls. Samples that underwent MB assisted ultrasound excitation 
exhibited 17% increase in GAG production after 3 weeks. However, samples treated with LIPUS only, had a 5% 
increase in GAG production after 3 weeks compared to the controls.
In addition to improved GAG production, Fig. 7(b) illustrates another important cartilage matrix protein-type 
II collagen synthesis. Type II collagen synthesis showed 44% and 78% increase after 3 weeks for US only and US/
MB groups, respectively, when compared to the controls. The results elucidate the effective role of LIPUS and MBs 
assisted with 3D-printed scaffolds for enhanced chondrogenic differentiation of hMSCs.
Mechanism of cellular effects of LIPUS in the presence of MB. As we already noted, the exact mech-
anism behind the effects of ultrasound on cells is not completely understood. However, growing evidence suggests 
that mechanical stimulation in the environment of the cells significantly affects synthesis and degradation of 
Figure 5. (a) 1, 3 and 5-day hMSC proliferation with 3-min LIPUS (30 mW/cm2; 1.5 MHz; 20% duty cycle; 
200 μ s pulse length) and 0.5% MB suspension (Data are mean ± StdEM, n = 9). Microscopic images of hMSC 
growth two days after LIPUS (30 mW/cm2; 1.5 MHz; 20% duty cycle; 200 μ s) pulse length). (b) Control, (c) 
LIPUS, (d) LIPUS with 0.5% (v/v) MB suspension. Values significantly different from the control group are 
indicated by *for p < 0.05 and **for p < 0.01.
www.nature.com/scientificreports/
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matrix macromolecules, activates distinct regulatory pathways of metabolic functions and changes the level of 
transcription, translation, and post-translational modification57–59. In particular, application of fluid shear to oste-
oblasts—relevance of which will become clear below—induces development of thicker and more abundant actin 
filaments (stress fibers) as well as formation of focal adhesions containing β1-integrins and α-actin60. They in turn 
play a central role in signal transduction from extra cellular matrix (ECM) to the nucleus leading to an increased 
gene expression61. While dynamic compression has been shown to stimulate genes associated with chondrogene-
sis in hMSCs, dynamic tension was found to regulate both fibroblastic and osteogenic associated genes62.
Unlike steady mechanical stimulation as in tension, compression or fluid shear, LIPUS subjects the cells to a 
periodically varying load triggering one, many, or all of the above bioeffects. Cellular effects of LIPUS are gen-
erally categorized to be non-thermal63, predominantly due to cavitation, microstreaming and acoustic radiation 
forces64,65. Cavitation refers to the growth, oscillation, and/or collapse of gaseous cavities under excitation of 
acoustic waves66,67. Stable oscillations at low excitations create microstreaming, a fluid flow, around MBs caus-
ing cells to experience higher levels of shear stress, ranging between 100 Pa to 1 kPa. At higher excitations, MBs 
undergo nonlinear inertial cavitation, eventual bubble collapse and direct liquid jets towards nearby cell lay-
ers35,38,68. In fact, several in vitro as well as in vivo studies have demonstrated MBs in conjunction with ultrasound 
Figure 6. Effects of 3-min LIPUS (30 mW/cm2;1.5 MHz; 20% duty cycle; 200 μ s pulse length unless otherwise 
specified for each parameter variation) stimulation at varying (a) intensity, (b) duty cycle, (c) frequency and 
(d) excitation duration in the presence of 0.5% (v/v) MB suspension on day 1 (Data are mean ± StdEM, n = 9). 
Values significantly different from control group are indicated by *for p < 0.05 and **for p < 0.01.
Figure 7. Three-week hMSC (a) GAG production and (b) type II collagen. (Data are mean ± StdEM, n = 5). 
Values significantly different from the control group are indicated by *for p < 0.05 and **for p < 0.01.
www.nature.com/scientificreports/
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results in a process called sonoporation, transient development of pores in cell membranes34,69–73. The pores have 
been visualized by scanning electron microscopy (SEM), transmission electron microscopy (TEM) and ultrafast 
real time imaging74–76. In any event, we believe that, at the low excitation intensity of 30 mW/cm2 applied here, 
oscillating MBs can generate higher shear stresses on adjacent cells through microstreaming and stable cavita-
tion. Note that ultrasound alone was also seen here to generate cellular effects though of a much lesser strength 
compared to when MBs were present.
Conclusion
In this study, we designed and fabricated a novel 3D printed scaffold for cartilage regeneration. We explored for 
the first time the application of lipid-coated, perfluorobutane-filled microbubbles along with LIPUS as a means to 
enhance hMSC growth and their chondrogenic differentiation. Although microbubbles and their response in the 
presence of ultrasound excitation have been extensively investigated for their therapeutic effects, their applica-
tions were thus far restricted to non-tissue engineering applications. Here, it is introduced to tissue engineering, 
specifically for cartilage regeneration in three dimensional scaffolds. Our results show that LIPUS in combination 
with MB on 3D printed constructs can significantly enhance hMSC proliferation—as much as by 40%—as well 
as chondrogenic differentiation. Therefore, integrating LIPUS and MB appears to be a promising strategy for 
enhanced hMSC growth and chondrogenic differentiation.
Methods
Preparation of 3D-printed scaffolds. A tabletop stereolithography-based 3D bioprinter was used to fab-
ricate structured scaffolds (Fig. 1). The printer consists of a 3D axial movable stage and a UV laser source. The 
printing configuration is controlled by a Pronterface control software package. It can generate different geomet-
rical patterns using 3D computer aided design (CAD) models. Previously, we found that scaffolds with square 
pore patterns had higher hMSC growth and differentiation rates. Therefore, we chose the same pattern for our 
differentiation studies. The print speed was maintained at 25 mm/s and the laser repetition rate used to print the 
structured patterns varied from 8 to 11 kHz. The 3D scaffold was printed via layer by layer method. Bioink was 
prepared by mixing 40% (w/w) poly (ethylene glycol) (PEG, Mn 300) and 60% (w/w) poly (ethylene glycol) dia-
crylate (PEG-DA, Mn 575) in the presence of the photo initiator (0.5% (w/w) of PEG-DA)77,78. The morphology 
of the scaffolds was observed by a scanning electron microscope (SEM, Zeiss NVision 40FIB).
Lipid-coated microbubble formulation and preparation. Lipid emulsions were formulated by 
dissolution of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC), 1,2-dipalmitoyl-sn-glycero-3-p
hosphatidylethanolamine-polyethyleneglycol-2000 (DPPE-PEG-2000) and 1,2-dipalmitoyl-3-t
rimethylammonium propane (chloride salt; 16:0 TAP) (Avanti, AL) at a total lipid concentration of 0.75, 1.5, and 
3 mg/mL. In order to have a homogenous solution of lipids, lipids were mixed in propylene glycol and heated in 
a sonication bath above the lipid transition temperature (45 °C) for approximately 30 minutes. PBS and glycerol 
were added later to the lipid solution79,80. After the lipid solution was further mixed using a magnetic stirrer, 
1.5 ml of the resulting solution was added to a 3-ml glass vial. The remaining head space was gas exchanged 
with perfluorobutane (PFB) (Fluoromed, TX) and MBs were formed via mechanical agitation technique using 
Vial Mixer (Bristol Myers Squibb) for 45 seconds. After the production of MBs, we performed a two-minute 
centrifugation technique at 40 relative centrifugal force (RCF) to remove bubbles with larger diameters using 
a bucket-rotor centrifuge as described in details elsewhere52,53. The size and number of MBs were determined 
using the qNano (Izon Science™ , MA). For the measurements, we used three nanopore membranes, NP4000: 
(2000 nm–10000 nm), NP2000: (1000 nm–5000 nm) and NP1000: (400 nm–1500 nm), to accurately compare the 
size distribution and concentration of our original and centrifuged MBs. The morphology of lipid-coated micro-
bubbles was observed under microscope (AmScope FMA050, MA at 40× ).
In vitro cell culture. hMSCs (passage #3–6) were cultured in complete media composed of Alpha Minimum 
Essential medium (α-MEM) (Gibco, Grand Island, NY) supplemented with fetal bovine serum (FBS) (16%, v/v) 
(Atlanta Biologicals, Lawrenceville, GA), L-glutamine (1% v/v) (Invitrogen, Carlsbad, CA) and penicillin:strep-
tomycin (1% v/v) (Invitrogen, Carlsbad, CA). Cells were incubated under standard cell culture conditions (37 °C, 
5% CO2 and 95% relative humidity). For chondrogenesis, 100 nM dexamethasone, 40 μ g/mL proline, 100 μ g/mL 
sodium pyruvate, 50 mg/mL L-ascorbic acid 2-phosphate and 1% ITS were added to the above complete media. 
Media were replaced every other day.
Determination of hMSC proliferation under LIPUS and MB treatment. Cells were seeded at a den-
sity of 15 × 103 per well in 24-well plates overnight before LIPUS and MB experiments to permit cell attachment 
to the plates. On the next day, the media were replaced to remove non-adherent cells. After LIPUS and MB treat-
ments for predetermined periods, samples were rinsed using phosphate buffer saline (PBS) and the cells were 
lifted with 0.25% trypsin-EDTA solution. Cell proliferation was quantified via CellTiter 96 Aqueous Solution Cell 
Proliferation assay (MTS) (Promega, Madison, WI) and analyzed using a spectrophotometer at 490 nm (Thermo, 
USA)81.
Determination of chondrogenic differentiation under LIPUS and MB treatment. All scaffolds 
for differentiation studies were seeded at a density of 1 × 105 cells per scaffold. Prior to cell seeding, the samples 
were sterilized via UV exposure and then rinsed with PBS three times. Subsequently, the sterilized samples were 
pre-soaked in culture media for 24 hours before cell seeding. After predetermined time periods of LIPUS and MB 
treatments (the same as described above), these samples were collected after 1, 2 and 3 weeks to evaluate hMSC 
chondrogenesis. Media were removed from the samples and the latter rinsed with PBS. The collected samples 
were freeze dried in a lyophilizer and treated in a Papain digestion solution for 18 hours in a 60 °C water bath. 
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Glycosaminoglycan (GAG) and collagen type II, which are two key components of cartilage matrix, were meas-
ured using standard assay kits following manufacturer’s instructions. Details of the process can be found in81,82.
Ultrasound excitation. The schematic representation of ultrasound exposure setup is shown in Fig. 8. 
Briefly, the ultrasound pulse was produced by a programmable function generator (33250 A, Agilent, Palo Alto, 
CA, USA), amplified by a broadband 55 dB laboratory RF power amplifier (model A-150, ENI, Rochester, NY, 
USA) and then emitted from a single element unfocused immersion transducer. The outside diameter of the 
transducers was 16 mm. For frequency-dependent studies, we used unfocused immersion transducers (Olympus 
NDT, Waltham, MA) with central frequencies of 2.25 MHz (− 6 dB: 1.48–2.90 MHz) and 3.5 MHz (− 6 dB: 2.5–
4.99 MHz). All the transducers were sterilized with 75% ethanol and kept under ultraviolet light overnight before 
the experiments.
To conduct this study, the transducer head was placed vertically on the top of the culture plate until it touched 
the media. In this configuration, the working distance of approximately 12 mm from the cell culture surface was 
fixed and kept constant throughout all experiments. Since the reflection coefficient of air-polystyrene interface is 
much higher than polystyrene-water interface, the 24-well plates were placed in a circular (5.5 inches in diameter) 
aluminum container filled with water.
Prior to ultrasound exposure the cells were washed two times with PBS. Ultrasound was applied to the cells 
after adding 3 mL of medium to each well. For cells being exposed to ultrasound and MBs, a mixture of culture 
media and MBs were first prepared separately and then pipetted into each well. To determine the optimal con-
centration of MBs as well as ultrasonic parameters we perform experiments varying intensity (10–300 mW/cm2), 
duty cycle (0.02–80%), frequency (1.5–3.5 MHz) and excitation duration (1–5 min) in the presence of MBs. Note 
that in all the experiments the pulse length is 200 μ s. The duty cycle is the ratio of the actual pulse length to the 
pulse repetition period (PRP). The PRP is the inverse of the pulse repetition frequency (PRF). Control groups 
underwent the same submersion and withdrawal of transducers without any MB and with ultrasound power 
turned off.
Statistical analysis. All proliferation studies were run in triplicate and repeated three times (n = 9). For 
the chondrogenic differentiation study, 5 replicates were performed (n = 5). Data are presented as mean ± stand-
ard error of the mean (StdEM) and analyzed by the Student’s t-test. A p < 0.05 was considered as statistically 
significant.
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